The cost offsets and cost-effectiveness associated with pegylated drugs: a review of the literature

Author： Becker Russell Dembek Carole White Leigh Ann Garrison Louis P

ISSN： 1473-7167

Source： Expert Review of Pharmacoeconomics and Outcomes Research, Vol.12, Iss.6, 2012-12, pp. : 775-793

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Cost-Effectiveness of Clozapine: A Survey of the Literature

By Morris S.

Clinical Drug Investigation, Vol. 15, Iss. 2, 1998-02 ,pp. : 137-152

Adis International

Access to resources Recommend Favorite

A systematic review of cost-effectiveness analyses of pharmacogenomic interventions

By Phillips Kathryn A Van Bebber Stephanie L

Pharmacogenomics, Vol. 5, Iss. 8, 2004-12 ,pp. : 1139-1149

Future Medicine

Access to resources Recommend Favorite

Historical Lifetimes of Drugs in England: Application to Value of Information and Cost-Effectiveness Analyses

By Hoyle Martin

Value in Health, Vol. 13, Iss. 8, 2010-12 ,pp. : 885-892

Blackwell Publishing

Access to resources Recommend Favorite

Immunomodulatory drugs for multiple sclerosis: a systematic review of clinical and cost effectiveness

By Clegg A. Bryant J.

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 4, 2001-04 ,pp. : 623-639

Informa Healthcare

Access to resources Recommend Favorite

Cost–effectiveness analysis in pharmacogenomics

By Payne Katherine Shabaruddin Fatiha H

Pharmacogenomics, Vol. 11, Iss. 5, 2010-05 ,pp. : 643-646

Future Medicine

Access to resources Recommend Favorite